Abeona Therapeutics Announces Participation in Upcoming Investor Conferences
May 07 2019 - 4:15PM
Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader
in gene and cell therapy, today announced its participation in the
following upcoming investor conferences.
- SunTrust Robinson Humphrey 5th Annual Life Science Summit
One-on-one Meetings May 8, 2019 Lotte New York Palace, New York,
NY
- 2019 RBC Capital Markets Healthcare Conference Fireside Chat
May 22, 2019, 1:35 p.m. ET The InterContinental New York
Barclay Hotel, New York, NY
- Jefferies 2019 Global Healthcare Conference Corporate
Presentation June 5, 2019, 2:30 p.m. ET Grand Hyatt, New York,
NY
Live webcasts of the fireside chat and corporate
presentation will be available on the investor section of the
Abeona Therapeutics website, www.abeonatherapeutics.com, and
archived replays will be accessible for up to 30 days.
About Abeona TherapeuticsAbeona
Therapeutics Inc. is a clinical-stage biopharmaceutical company
developing gene and cell therapies for serious diseases. The
Company’s clinical programs include EB-101, its autologous,
gene-corrected cell therapy for recessive dystrophic epidermolysis
bullosa, as well as ABO-102 and ABO-101, novel AAV9-based gene
therapies for Sanfilippo syndrome types A and B (MPS IIIA and MPS
IIIB). The Company’s portfolio of AAV9-based gene therapies also
features ABO-202 and ABO-201 for CLN1 disease and CLN3 disease,
respectively. Its preclinical assets include ABO-401, which uses
the novel AIM™ AAV vector platform to address all mutations of
cystic fibrosis. Abeona has received numerous regulatory
designations from the FDA and EMA for its pipeline candidates and
is the only company with Regenerative Medicine Advanced Therapy
designation for two investigational therapies (EB-101 and ABO-102).
For more information, visit www.abeonatherapeutics.com.
Investor Contact:Sofia
WarnerSenior Director, Investor RelationsAbeona Therapeutics+1
(646) 813-4710swarner@abeonatherapeutics.com
Media Contact:Scott
SantiamoDirector, Corporate CommunicationsAbeona Therapeutics+1
(718) 344-5843ssantiamo@abeonatherapeutics.com
Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Apr 2023 to Apr 2024